Blood pressure medication recalled nationwide over potential ineffectiveness
Key Points:
- More than 11,000 bottles of 25 mg Chlorthalidone blood pressure medication have been recalled nationwide due to failure to meet dissolution specifications, potentially making the drug less effective or incorrectly dosed.
- The recall affects 100-tablet and 1,000-tablet bottles with batch numbers RISA24001 and RISB24002, and an expiration date of April 2027.
- The medication was manufactured by Inventia Healthcare Limited in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, New Jersey.
- Patients using this medication are advised to consult their healthcare providers to discuss alternative treatments or next steps.